Research & Development

The human body hosts trillions of microorganisms, but recent discoveries reveal that the specific bacteria colonizing cancerous tumors may hold the definitive key to predicting a patient’s chances of survival, potentially revolutionizing cancer prognosis. While cancer has long been viewed primarily

The long-standing battle against cancer has often been waged with standardized weapons, yet the outcomes for patients with identical diagnoses can diverge dramatically, leaving both clinicians and families questioning the unpredictability of the fight. A groundbreaking clinical trial now provides a

A fractured bone unleashes an immediate and intense cascade of pain signals, but new evidence compellingly suggests these very same messengers are also the architects of their own repair. For decades, the nervous system's role in skeletal injury was viewed through a narrow lens: nerves reported

As a leading expert in biopharma innovation, Ivan Kairatov has dedicated his career to the intersection of technology and medicine. His work focuses on pioneering new frontiers in research and development, particularly in creating intelligent therapeutic systems. Today, he shares his insights on a

The development of new medicines for the most critically ill patients is a path fraught with immense challenges, where promising breakthroughs can be abruptly overshadowed by unforeseen safety concerns. In a significant and unexpected development, London-based biopharmaceutical company Pulmocide

A groundbreaking study has decisively answered a question at the forefront of modern medicine, confirming that a cancer treatment tailored to the unique genetic fingerprint of a patient's tumor is not only possible but also significantly more effective and safe than conventional approaches.